Angle PLC – Parsortix used in new cancer assessment technique
18th April 2019
ANGLE plc (AIM:AGL), a world-leading liquid biopsy company, is pleased to announce that top US cancer centre, the University of Texas MD Anderson Cancer Center has developed a new technique...
Read More